Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: syncope major surgical or invasive procedure: cardiac catheterization with rotational atherectomy of rca and bare metal stenting of proximal and mid right coronary artery. history of present illness: 77m pmh copd, htn, hypertrophic cm--hocm/ihss, recently admitted to with syncope. pt notes that he was walking to the bathroom when he felt sob, then loc x 1 min. no lh, cp, palpitations. stayed home over the weekend, then continued to feel increasing sob, lh; and came in to . while in the ed at , he was noted to have svt with stable vitals. he was give adenosine, then started on a dilt gtt overnight. in the am on , he was noted on labs to have a trop increase from 0.56 to 1.82 (ck 86-->115, mb 5.2-->6.6). he was medically managed initially, then transferred to for cath. . in the cath lab, he was noted to have a tortuous and heavily calcified mid rca that was unable to be expanded with the balloon. rotational atherectomy was performed, but still with suboptimal balloon expansion. attempt to deliver an 18mm cypher stent was unsuccessful, so 3 small bare metal stents were placed overlapping, with good flow afterwards. past medical history: hcm--ihss squamous cell ca skin, mets to r hypopharynx, s/p xrt and radical neck dissection . htn irregular heart beat smoking history (60 pack-years) no family history of cardiac disease/sudden death social history: current smoker family history: nc physical exam: g: elderly male, nad heent: mmm, clear op neck: no jvd lungs: crackles bl at bases, no w/r] cv: rrr, s1s2, no appreciable murmur abd: soft, nt, bs+ ext: no edema neuro: a&ox3, appropriate. no focal deficits. pertinent results: admission labs: 07:30pm blood wbc-9.3 rbc-3.79* hgb-11.9* hct-34.4* mcv-91 mch-31.5 mchc-34.7 rdw-14.7 plt ct-266 11:40am blood pt-13.2 inr(pt)-1.2 07:30pm blood plt ct-266 10:39pm blood glucose-184* urean-15 creat-0.8 na-136 k-4.3 cl-101 hco3-29 angap-10 10:39pm blood ck(cpk)-54 05:41am blood alt-10 ast-15 ld(ldh)-158 ck(cpk)-47 alkphos-68 totbili-0.8 10:39pm blood ck-mb-notdone 05:41am blood ck-mb-notdone 10:39pm blood calcium-8.2* phos-3.3 mg-1.6 05:41am blood albumin-3.4 calcium-8.1* phos-3.1 mg-1.6 cholest-129 05:41am blood triglyc-77 hdl-40 chol/hd-3.2 ldlcalc-74 05:41am blood tsh-1.5 05:41am blood free t4-1.1 03:12pm blood type-art po2-64* pco2-37 ph-7.45 calhco3-27 base xs-1 intubat-not intuba discharge labs: 07:12am blood wbc-6.9 rbc-3.92* hgb-12.0* hct-35.5* mcv-91 mch-30.7 mchc-33.9 rdw-14.4 plt ct-294 07:12am blood plt ct-294 07:12am blood pt-12.7 ptt-25.1 inr(pt)-1.1 07:12am blood glucose-92 urean-22* creat-0.9 na-137 k-4.1 cl-103 hco3-23 angap-15 07:12am blood calcium-9.2 phos-3.2 mg-2.0 cath results: co 4.21/ci 2.27 pcw m/a/v: 31/30/38 ra m/a/v: ao: s/d/m: 210/79/126 pa: s/d/m: 64/24/42 lv: s/d/e: 209/13/26 rv: s/d/e: hr 60s mv: grad 9.27, flow 149.4, area 1.30, index 0.70 fluoro x 125 min contrast 465 cc lvgraphy: not performed due to severe pa htn r dom: lmca, lad, lcx non-obstructed om: lower pole severe diffuse disease in a small vessel rca: 90% prox and mid vessels. * echo: measurements: left atrium - long axis dimension: *4.9 cm (nl <= 4.0 cm) left atrium - four chamber length: *6.0 cm (nl <= 5.2 cm) right atrium - four chamber length: *6.0 cm (nl <= 5.0 cm) left ventricle - septal wall thickness: *1.8 cm (nl 0.6 - 1.1 cm) left ventricle - inferolateral thickness: 1.1 cm (nl 0.6 - 1.1 cm) left ventricle - diastolic dimension: 4.6 cm (nl <= 5.6 cm) left ventricle - ejection fraction: >= 70% (nl >=55%) aorta - valve level: 3.2 cm (nl <= 3.6 cm) aorta - ascending: 3.2 cm (nl <= 3.4 cm) aorta - arch: 2.8 cm (nl <= 3.0 cm) aortic valve - peak velocity: *2.2 m/sec (nl <= 2.0 m/sec) aortic valve - peak gradient: 20 mm hg aortic valve - mean gradient: 10 mm hg mitral valve - mean gradient: 3 mm hg mitral valve - pressure half time: 124 ms mitral valve - mva (p t): 1.9 cm2 mitral valve - e wave: 1.4 m/sec mitral valve - a wave: 1.0 m/sec mitral valve - e/a ratio: 1.40 mitral valve - e wave deceleration time: 380 msec tr gradient (+ ra = pasp): *44 mm hg (nl <= 25 mm hg) interpretation: findings: left atrium: mild la enlargement. right atrium/interatrial septum: mildly dilated ra. left ventricle: severe symmetric lvh. normal regional lv systolic function. no resting or inducible lvot gradient. right ventricle: normal rv chamber size and free wall motion. aorta: normal aortic root diameter. normal ascending aorta diameter. normal aortic arch diameter. aortic valve: mildly thickened aortic valve leaflets (3). minimally increased gradient c/w minimal as. trace ar. mitral valve: mildly thickened mitral valve leaflets. moderate mitral annular calcification. mild thickening of mitral valve chordae. mnimally increased gradient consistent with trivial ms. mild to moderate (+) mr. tricuspid valve: normal tricuspid valve leaflets. mild tr. moderate pa systolic hypertension. pericardium: no pericardial effusion. general comments: suboptimal image quality - poor parasternal views. based on aha endocarditis prophylaxis recommendations, the echo findings indicate a moderate risk (prophylaxis recommended). clinical decisions regarding the need for prophylaxis should be based on clinical and echocardiographic data. conclusions: the left atrium is mildly dilated. there is severe symmetric left ventricular hypertrophy with relative sparing of the inferior and inferolateral walls and normal cavity size.. regional left ventricular wall motion is normal. there is no left ventricular outflow obstruction at rest or with valsalva. right ventricular chamber size and free wall motion are normal. the aortic valve leaflets (3) are mildly thickened. there is a minimally increased gradient consistent with minimal aortic valve stenosis. trace aortic regurgitation is seen. the mitral valve leaflets are mildly thickened. there is prominent mitral annular calcification leading to minimal functional mitral stenosis. mild to moderate (+) mitral regurgitation is seen. there is moderate pulmonary artery systolic hypertension. there is no pericardial effusion. impression: hypertrophic non-obstructive cardiomyopathy with preserved regional systolic function. pulmonary artery systolic hypertension. mild-moderate mitral regurgitation. minimal aortic stenosis and minimal mitral stenosis. brief hospital course: cardiac: . a) cor: nstemi, s/p rota atherectomy of rca with placement of 3 bare metal stents. other coronary anatomy includes r dominant system only otherwise significant for diffusely diseased om. pt was started on aspirin, plavix, statin, beta blocker, and integrillin x 18 hours post cath. his acei was initially held given concerns about dye nephropathy from prolonged exposure, but this was restarted as his renal function was stable. . b) pump: history of ihss. echo from osh reveals severe septal hypertrophy, mitral stenosis (peak 10, mean 5) mild mr , ef > 75%, rvh, peak lvot gradient 14mmhg, mean 9, no evidence . the patient was transferred to the floor with bps in the 200 systolic. he was started on a nitro drip, and oral antihypertensives were gradually added back. his echo was significant for a lack of apparent lv outflow tract obstruction/gradient, and his response to blood pressure medications did not indicate that this was a significant issue. he was eventually discharged on a regimen of hctz, lisinopril, nifedipine, atenolol, all of which can be titrated as an outpatient. . c) rhythm: the patient continued to have brief episodes of atrial fibrillation while on telemetry. he was seen by ep, and started on amiodarone (to be tapered as an outpatient) and well as titrated up on nodal agents. he was also without major risk factors for sudden death, and was determined not to be a candidate for icd placement. his heart rate was in the low 60s on discharge. he was also started on coumadin, after his hematocrit was determined to be stable (see below), and can have his inr followed as an op. he is discharged with of hearts monitor. * renal: pt exposed to large dye load (500cc) during the cath, and there was a concern for dye nephropathy; however, his creatinine remained stable throughout. he was also given iv bicarbonate and mucomyst post cath. * gi: the patient was noted to have had a decrease in hct several days post cath. his stool was brown (not melanic or brbpr), but was guaiac positive. an ngt lavage was clear with no blood or bile. he was transfused 1 unit of prbcs with a good response in hct, and remained stable throughout. he should have a gi workup for this as an outpatient. * neuro: ? age indeterminant infarct on head ct, although pt not aware of cva. neuro exam only notable for l facial droop. no active issues during this hospitalization. continued on aspirin. * dermatology: the patient had an extended cath time with fluoro exposure lasting greater than 100 minutes. he is to follow up with dermatology as an outpatient. * copd: no symptoms during this admission. * medications on admission: outpatient med list unavailable on admission discharge medications: 1. amiodarone hcl 200 mg tablet sig: one (1) tablet po bid (2 times a day) for 4 weeks: after 4 weeks, you need to reduce your dose to 1 tablet daily. disp:*56 tablet(s)* refills:*1* 2. aspirin 325 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). 3. clopidogrel bisulfate 75 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 4. albuterol-ipratropium 103-18 mcg/actuation aerosol sig: puffs inhalation q6h (every 6 hours) as needed. 5. atorvastatin calcium 10 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 6. lisinopril 20 mg tablet sig: two (2) tablet po daily (daily). disp:*60 tablet(s)* refills:*2* 7. warfarin sodium 5 mg tablet sig: one (1) tablet po hs (at bedtime). disp:*30 tablet(s)* refills:*2* 8. hydrochlorothiazide 25 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 9. nifedipine 30 mg tablet sustained release sig: one (1) tablet sustained release po daily (daily). disp:*30 tablet sustained release(s)* refills:*2* 10. atenolol 50 mg tablet sig: three (3) tablet po daily (daily). disp:*90 tablet(s)* refills:*2* 11. omeprazole 20 mg capsule, delayed release(e.c.) sig: one (1) capsule, delayed release(e.c.) po once a day. disp:*30 capsule, delayed release(e.c.)(s)* refills:*2* discharge disposition: home discharge diagnosis: hypertrophic cardiomyopathy coronary artery disease supraventricular tachycardia discharge condition: good discharge instructions: take all of your medications as directed. you need to quit smoking. this will not be easy, but it is the most important thing you can do to protect your heart. please talk with dr. about nicotine replacement options. please have your blood drawn (hct, pt/inr) in 3 days and follow up the results with dr. . followup instructions: we recommend the following: please make an appointment with dr. within 2-3 days of discharge. you will need to have your blood pressure checked on your new medication regimen. dr. should also draw your blood to check your inr after restarting your coumadin. you should also have your liver enzymes, thyroid function tests and pulmonary function tests monitored over time. you were started on amiodarone which requires these tests. finally, dr. should also schedule you to have another colonoscopy given you were noted to have blood in your stool during your hospital stay. you will be sent home with of hearts monitor to follow your rhythm. you need to call dr. office to schedule an appointment with him. his number is (. he will receive the results of your of hearts monitor. you will need to return for followup with electrophysiology within four weeks of discharge. provider: where: dermatology phone: date/time: 2:30 md, procedure: insertion of non-drug-eluting coronary artery stent(s) combined right and left heart cardiac catheterization coronary arteriography using two catheters insertion of temporary transvenous pacemaker system diagnoses: other primary cardiomyopathies subendocardial infarction, initial episode of care coronary atherosclerosis of native coronary artery tobacco use disorder chronic airway obstruction, not elsewhere classified atrial fibrillation other chronic pulmonary heart diseases unspecified disorder of kidney and ureter nonspecific abnormal findings in stool contents paroxysmal supraventricular tachycardia mitral stenosis personal history of malignant neoplasm of other and unspecified oral cavity and pharynx 

Answer: The patient is high likely exposed to